具有神经免疫能力的人脑类器官模型模拟弥漫性中线胶质瘤
研究构建了由人细胞组成的神经免疫能力脑/肿瘤融合类器官模型,将含小胶质细胞的脑类器官与H3K27M突变、TP53P27R/K132R弥漫性中线胶质瘤球融合,再现肿瘤弥漫浸润并显示小胶质细胞运动受外部因素和组织环境影响,作者认为该模型可用于机制研究和精准医学开发。
要点
- 构建MiCBO-TF融合类器官,含形态成熟、可运动的小胶质细胞和多种神经元亚型。
- 该模型再现弥漫性中线胶质瘤向脑组织的弥漫浸润模式。
- 小胶质细胞运动及与肿瘤细胞互动受外部因素和周围组织环境影响。
核心结论
- MiCBO-TF模型是用于弥漫性中线胶质瘤机制研究和精准医学方法开发的强有力平台。
研究设计与样本
- 研究构建了完全由人细胞组成的神经免疫能力脑/肿瘤融合类器官模型系统。
- 生成含小胶质细胞的脑类器官(MiCBOs),其携带形态成熟、可运动的小胶质细胞和多种神经元亚型。
- 将MiCBOs与H3K27M突变、TP53P27R/K132R弥漫性中线胶质瘤球融合,创建MiCBO-TF模型。
主要发现
- 利用活细胞成像同时追踪小胶质细胞胞体移动、突起运动及人脑组织环境中肿瘤细胞行为。
- MiCBO-TF模型忠实再现弥漫性中线胶质瘤向脑组织的弥漫浸润模式。
- 小胶质细胞运动及与肿瘤细胞的互动高度受外部因素和周围组织环境影响。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pediatric high-grade gliomas, such as diffuse midline glioma (DMG), have a poor prognosis and lack curative treatments. Current research models of DMG primarily rely on human DMG cell lines cultured in vitro or xenografted into the brains of immunodeficient mice. However, these models are insufficient to recapitulate the complex cell-cell interactions between DMG and the tumor-immune microenvironment (TIME), therefore fall short of accurately reflecting how efficacious therapeutic agents or combinations will be in the clinical setting. METHODS: To address these challenges, we developed a neuroimmune-competent brain/tumor fusion organoid model system consisting entirely of human cells to investigate the interactions between DMG cells and the primary innate immune cells of the brain, microglia, in the TIME at both cellular and subcellular levels. We generated microglia-containing brain organoids (MiCBOs) that carry morphologically mature, motile microglia and multiple subtypes of neurons to mimic the brain tumor microenvironment. These organoids were then fused with H3K27M mutant, TP53P27R/K132R DMG tumor spheroids to create the MiCBO-tumor fusion (MiCBO-TF) model. RESULTS: We utilized live imaging methods to simultaneously track the mobility of microglial cell bodies and the motility of their process, as well as the behavior of tumor cells within a human brain tissue environment. Our MiCBO-TF model faithfully recapitulated the diffuse infiltration pattern of DMG into brain tissue and revealed that microglial mobility and interactions with tumor cells are highly influenced by external factors and the surrounding tissue environment. CONCLUSIONS: The MiCBO-TF model represents a powerful platform for both mechanistic investigations and the development of precision medicine approaches for DMG.
引用
- Sarnow K, Majercak E, Qurbonov Q, et al. Neuroimmune-competent human brain organoid model of diffuse midline glioma. Neuro Oncol. 2025. PMID: 39561098. doi:10.1093/neuonc/noae245
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。